{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:03:03Z","timestamp":1782831783844,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00341030"],"award-info":[{"award-number":["RS-2024-00341030"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00439930"],"award-info":[{"award-number":["RS-2024-00439930"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01050-y","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:59:27Z","timestamp":1754524767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optic neuritis as a link between autoimmunity and dementia risk"],"prefix":"10.1038","volume":"5","author":[{"given":"Jaeryung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-1263","authenticated-orcid":false,"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Yeul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-5635","authenticated-orcid":false,"given":"Kyung-Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"1050_CR1","unstructured":"G. B. D. Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105\u2013e125 (2022)."},{"key":"1050_CR2","doi-asserted-by":"crossref","unstructured":"2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 18, 700\u2013789 (2022).","DOI":"10.1002\/alz.12638"},{"key":"1050_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2217\/nmt-2022-0037","volume":"13","author":"H Hampel","year":"2023","unstructured":"Hampel, H. et al. The amyloid-beta pathway in Alzheimer\u2019s disease: a plain language summary. Neurodegener. Dis. Manag. 13, 141\u2013149 (2023).","journal-title":"Neurodegener. Dis. Manag."},{"key":"1050_CR4","doi-asserted-by":"publisher","first-page":"679837","DOI":"10.3389\/fnagi.2021.679837","volume":"13","author":"AM Hakim","year":"2021","unstructured":"Hakim, A. M. A proposed hypothesis on dementia: inflammation, small vessel disease, and hypoperfusion is the sequence that links all harmful lifestyles to cognitive impairment. Front. Aging Neurosci. 13, 679837 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1050_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker, A. & Cotman, C. W. Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease. Neurobiol. Aging 107, 86\u201395 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1050_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","volume":"22","author":"JL Bennett","year":"2023","unstructured":"Bennett, J. L. et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol 22, 89\u2013100 (2023).","journal-title":"Lancet Neurol"},{"key":"1050_CR7","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","volume":"77","author":"T Braithwaite","year":"2020","unstructured":"Braithwaite, T. et al. Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease. JAMA Neurol. 77, 1514\u20131523 (2020).","journal-title":"JAMA Neurol."},{"key":"1050_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.903608","volume":"9","author":"KS Ma","year":"2022","unstructured":"Ma, K. S. et al. Risk of autoimmune diseases following optic neuritis: a nationwide population-based cohort study. Front. Med. 9, 903608 (2022).","journal-title":"Front. Med."},{"key":"1050_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/alz.12789","volume":"19","author":"DF Weaver","year":"2023","unstructured":"Weaver, D. F. Alzheimer\u2019s disease as an innate autoimmune disease (AD(2)): a new molecular paradigm. Alzheimers Dement. 19, 1086\u20131098 (2023).","journal-title":"Alzheimers Dement."},{"key":"1050_CR10","doi-asserted-by":"publisher","first-page":"e0186475","DOI":"10.1371\/journal.pone.0186475","volume":"13","author":"TM Lin","year":"2018","unstructured":"Lin, T. M. et al. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: a nationwide cohort study. PLoS ONE 13, e0186475 (2018).","journal-title":"PLoS ONE"},{"key":"1050_CR11","doi-asserted-by":"publisher","first-page":"e2332635","DOI":"10.1001\/jamanetworkopen.2023.32635","volume":"6","author":"J Janbek","year":"2023","unstructured":"Janbek, J. et al. Hospital-diagnosed infections, autoimmune diseases, and subsequent dementia incidence. JAMA Netw. Open 6, e2332635 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1050_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s43587-022-00293-x","volume":"2","author":"JV Lindbohm","year":"2022","unstructured":"Lindbohm, J. V. et al. Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases. Nat. Aging 2, 956\u2013972 (2022).","journal-title":"Nat. Aging"},{"key":"1050_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","volume":"40","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. et al. Data analytic process of a Nationwide Population-based study using national health information database established by National Health Insurance Service. Diabetes Metab. J. 40, 79\u201382 (2016).","journal-title":"Diabetes Metab. J."},{"key":"1050_CR14","doi-asserted-by":"publisher","first-page":"120673","DOI":"10.1016\/j.jns.2023.120673","volume":"450","author":"GI Lee","year":"2023","unstructured":"Lee, G. I., Han, K., Park, K. A. & Oh, S. Y. Risk of optic neuritis in type 2 diabetes mellitus: a nationwide cohort study. J. Neurol. Sci. 450, 120673 (2023).","journal-title":"J. Neurol. Sci."},{"key":"1050_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7570\/jomes23016","volume":"32","author":"KK Kim","year":"2023","unstructured":"Kim, K. K. et al. Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the korean society for the study of obesity. J. Obes. Metab. Syndr. 32, 1\u201324 (2023).","journal-title":"J. Obes. Metab. Syndr."},{"key":"1050_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ophtha.2023.10.006","volume":"131","author":"J Kim","year":"2024","unstructured":"Kim, J., Han, K., Jung, J. H., Park, K. A. & Oh, S. Y. Early-onset ocular motor cranial neuropathy is a strong predictor of dementia: a nationwide, population-based cohort study. Ophthalmology 131, 288\u2013301 (2024).","journal-title":"Ophthalmology"},{"key":"1050_CR17","doi-asserted-by":"publisher","first-page":"e2254771","DOI":"10.1001\/jamanetworkopen.2022.54771","volume":"6","author":"KH Jeon","year":"2023","unstructured":"Jeon, K. H. et al. Changes in alcohol consumption and risk of dementia in a Nationwide Cohort in South Korea. JAMA Netw. Open 6, e2254771 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1050_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413\u2013446 (2020).","journal-title":"Lancet"},{"key":"1050_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol. Neurodegener. 15, 40 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1050_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein, S. et al. Two randomized phase 3 studies of Aducanumab in Early Alzheimer\u2019s disease. J. Prev. Alzheimers Dis. 9, 197\u2013210 (2022).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1050_CR21","doi-asserted-by":"publisher","first-page":"o3010","DOI":"10.1136\/bmj.o3010","volume":"379","author":"S Walsh","year":"2022","unstructured":"Walsh, S., Merrick, R., Richard, E., Nurock, S. & Brayne, C. Lecanemab for Alzheimer\u2019s disease. BMJ 379, o3010 (2022).","journal-title":"BMJ"},{"key":"1050_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig, L. S. et al. Trial of Solanezumab for mild dementia due to Alzheimer\u2019s disease. N. Engl. J. Med. 378, 321\u2013330 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1050_CR23","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","volume":"146","author":"H Florian","year":"2023","unstructured":"Florian, H. et al. Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study. Brain 146, 2275\u20132284 (2023).","journal-title":"Brain"},{"key":"1050_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"1050_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"1050_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/biomedicines11020408","volume":"11","author":"RI Mehta","year":"2023","unstructured":"Mehta, R. I. & Mehta, R. I. The vascular-immune hypothesis of Alzheimer\u2019s disease. Biomedicines 11, 408 (2023).","journal-title":"Biomedicines"},{"key":"1050_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0038-1660480","volume":"38","author":"JM Long","year":"2018","unstructured":"Long, J. M. & Day, G. S. Autoimmune dementia. Semin. Neurol. 38, 303\u2013315 (2018).","journal-title":"Semin. Neurol."},{"key":"1050_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4065\/mcp.2010.0326","volume":"85","author":"EP Flanagan","year":"2010","unstructured":"Flanagan, E. P. et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin. Proc. 85, 881\u2013897 (2010).","journal-title":"Mayo Clin. Proc."},{"key":"1050_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1073858420908189","volume":"26","author":"YI Arshavsky","year":"2020","unstructured":"Arshavsky, Y. I. Alzheimer\u2019s disease: from amyloid to autoimmune hypothesis. Neuroscientist 26, 455\u2013470 (2020).","journal-title":"Neuroscientist"},{"key":"1050_CR30","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1021\/acschemneuro.9b00333","volume":"10","author":"KA Walker","year":"2019","unstructured":"Walker, K. A., Ficek, B. N. & Westbrook, R. Understanding the role of systemic inflammation in Alzheimer\u2019s disease. ACS Chem. Neurosci. 10, 3340\u20133342 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1050_CR31","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu, A., Li, S., Gao, F. & Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front. Aging Neurosci. 16, 1347987 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"1050_CR32","doi-asserted-by":"publisher","first-page":"15271","DOI":"10.3390\/ijms232315271","volume":"23","author":"A Aragon-Gonzalez","year":"2022","unstructured":"Aragon-Gonzalez, A., Shaw, P. J. & Ferraiuolo, L. Blood-brain barrier disruption and its involvement in neurodevelopmental and neurodegenerative disorders. Int. J. Mol. Sci. 23, 15271 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1050_CR33","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.3390\/ijms251910625","volume":"25","author":"F Shimizu","year":"2024","unstructured":"Shimizu, F. & Nakamori, M. Blood-brain barrier disruption in neuroimmunological disease. Int. J. Mol. Sci. 25, 10625 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1050_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3233\/JAD-231028","volume":"98","author":"NK Acharya","year":"2024","unstructured":"Acharya, N. K. et al. A chronic increase in blood-brain barrier permeability facilitates intraneuronal deposition of exogenous bloodborne Amyloid-Beta1-42 peptide in the brain and leads to Alzheimer\u2019s disease-relevant cognitive changes in a mouse model. J. Alzheimers Dis. 98, 163\u2013186 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"1050_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/biomedicines11030666","volume":"11","author":"MP Giannoccaro","year":"2023","unstructured":"Giannoccaro, M. P. et al. Neural surface antibodies and neurodegeneration: clinical commonalities and pathophysiological relationships. Biomedicines 11, 666 (2023).","journal-title":"Biomedicines"},{"key":"1050_CR36","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.tjpad.2024.100013","volume":"12","author":"Z Valiukas","year":"2025","unstructured":"Valiukas, Z., Tangalakis, K., Apostolopoulos, V. & Feehan, J. Microglial activation states and their implications for Alzheimer\u2019s Disease. J. Prev. Alzheimers Dis. 12, 100013 (2025).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1050_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamaneurol.2016.0150","volume":"73","author":"JS Yokoyama","year":"2016","unstructured":"Yokoyama, J. S. et al. Association between genetic traits for immune-mediated diseases and Alzheimer disease. JAMA Neurol. 73, 691\u2013697 (2016).","journal-title":"JAMA Neurol."},{"key":"1050_CR38","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41380-024-02510-y","volume":"29","author":"N Enduru","year":"2024","unstructured":"Enduru, N. et al. Genetic overlap between Alzheimer\u2019s disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence. Mol. Psychiatry 29, 2447\u20132458 (2024).","journal-title":"Mol. Psychiatry"},{"key":"1050_CR39","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson, Y., Shoenfeld, Y. & Amital, H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmun. 34, J258\u2013J265 (2010).","journal-title":"J. Autoimmun."},{"key":"1050_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrneurol.2010.1","volume":"6","author":"AE Handel","year":"2010","unstructured":"Handel, A. E., Giovannoni, G., Ebers, G. C. & Ramagopalan, S. V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat. Rev. Neurol. 6, 156\u2013166 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"1050_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson, T., Barcellos, L. F. & Alfredsson, L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13, 25\u201336 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"1050_CR42","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.2337\/db14-1488","volume":"64","author":"S Tsai","year":"2015","unstructured":"Tsai, S., Clemente-Casares, X., Revelo, X. S., Winer, S. & Winer, D. A. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases? Diabetes 64, 1886\u20131897 (2015).","journal-title":"Diabetes"},{"key":"1050_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini, M., Jeandel, P. Y., Rosenthal, E. & Shoenfeld, Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13, 981\u20131000 (2014).","journal-title":"Autoimmun. Rev."},{"key":"1050_CR44","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1212\/CON.0000000000000768","volume":"25","author":"JL Bennett","year":"2019","unstructured":"Bennett, J. L. Optic neuritis. Continuum (Minneap Minn) 25, 1236\u20131264 (2019).","journal-title":"Continuum (Minneap Minn)"},{"key":"1050_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med."},{"key":"1050_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-017-0428-6","volume":"5","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. Acta Neuropathol. Commun. 5, 25 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"1050_CR47","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/cimb44090272","volume":"44","author":"MA Ciapa","year":"2022","unstructured":"Ciapa, M. A., Salaru, D. L., Statescu, C., Sascau, R. A. & Bogdanici, C. M. Optic neuritis in multiple Sclerosis-A review of molecular mechanisms involved in the degenerative process. Curr. Issues Mol. Biol. 44, 3959\u20133979 (2022).","journal-title":"Curr. Issues Mol. Biol."},{"key":"1050_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy, A. T., Mason, D. F. & Miller, D. H. Optic neuritis. Lancet Neurol. 13, 83\u201399 (2014).","journal-title":"Lancet Neurol."},{"key":"1050_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/brain\/124.3.468","volume":"124","author":"A Brusa","year":"2001","unstructured":"Brusa, A., Jones, S. J. & Plant, G. T. Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 124, 468\u2013479 (2001).","journal-title":"Brain"},{"key":"1050_CR50","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1098\/rstb.1999.0510","volume":"354","author":"KJ Smith","year":"1999","unstructured":"Smith, K. J. & McDonald, W. I. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 1649\u20131673 (1999).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"1050_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/jnnp.68.4.441","volume":"68","author":"DJ Werring","year":"2000","unstructured":"Werring, D. J. et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J. Neurol. Neurosurg. Psychiatry 68, 441\u2013449 (2000).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1050_CR52","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/brain\/awm045","volume":"130","author":"K Korsholm","year":"2007","unstructured":"Korsholm, K., Madsen, K. H., Frederiksen, J. L., Skimminge, A. & Lund, T. E. Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas. Brain 130, 1244\u20131253 (2007).","journal-title":"Brain"},{"key":"1050_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.20448","volume":"57","author":"AT Toosy","year":"2005","unstructured":"Toosy, A. T. et al. Adaptive cortical plasticity in higher visual areas after acute optic neuritis. Ann. Neurol. 57, 622\u2013633 (2005).","journal-title":"Ann. Neurol."},{"key":"1050_CR54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-153-3-201008030-00260","volume":"153","author":"ML Daviglus","year":"2010","unstructured":"Daviglus, M. L. et al. National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann. Intern. Med. 153, 176\u2013181 (2010).","journal-title":"Ann. Intern. Med."},{"key":"1050_CR55","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace, R., Sleegers, K. & Van Broeckhoven, C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement 12, 733\u2013748 (2016).","journal-title":"Alzheimers Dement"},{"key":"1050_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.23838\/pfm.2021.00135","volume":"6","author":"DW Shin","year":"2022","unstructured":"Shin, D. W., Cho, J., Park, J. H. & Cho, B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med. 6, 9\u201331 (2022).","journal-title":"Precis Future Med."},{"key":"1050_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1192\/bjp.2020.54","volume":"218","author":"P Almeida-Meza","year":"2021","unstructured":"Almeida-Meza, P., Steptoe, A. & Cadar, D. Markers of cognitive reserve and dementia incidence in the English longitudinal study of ageing. Br. J Psychiatry 218, 243\u2013251 (2021).","journal-title":"Br. J Psychiatry"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01050-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01050-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01050-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:31:20Z","timestamp":1757345480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01050-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01050-y","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}